Axsome Therapeutics
AXSM
Axsome Therapeutics (AXSM) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $290.00 | Aug 31, 2026 |
| Mizuho | Maintained | Outperform | $316.00 from $306.00 | Aug 12, 2026 |
| Needham | Maintained | Buy | $268.00 from $267.00 | Aug 11, 2026 |
| Wells Fargo | Maintained | Overweight | $256.00 from $255.00 | Aug 11, 2026 |
| Guggenheim | Maintained | Buy | $275.00 from $260.00 | Aug 11, 2026 |
| RBC Capital | Maintained | Outperform | $297.00 from $304.00 | Aug 11, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $251.00 from $242.00 | Aug 11, 2026 |
| Mizuho | Maintained | Outperform | $306.00 from $310.00 | Jul 31, 2026 |
| BMO Capital | Initiated Coverage | Outperform | $310.00 | Jul 21, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $290.00 | Jul 15, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $290.00 | Jul 8, 2026 |
| RBC Capital | Maintained | Outperform | $304.00 from $302.00 | Jul 7, 2026 |
| TD Cowen | Maintained | Buy | $300.00 from $275.00 | Jun 17, 2026 |
| Needham | Maintained | Buy | $267.00 from $255.00 | May 5, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $290.00 from $270.00 | May 5, 2026 |
| Baird | Maintained | Outperform | $246.00 from $241.00 | May 5, 2026 |
| Mizuho | Maintained | Outperform | $310.00 from $228.00 | May 5, 2026 |
| Guggenheim | Maintained | Buy | $260.00 from $245.00 | May 5, 2026 |
| Wells Fargo | Maintained | Overweight | $255.00 from $225.00 | May 5, 2026 |
| RBC Capital | Maintained | Outperform | $302.00 from $242.00 | May 5, 2026 |
Frequently asked questions
What is the latest analyst rating on AXSM?
On Aug 31, 2026, HC Wainwright & Co. maintained Axsome Therapeutics at Buy with a price target of $290.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.